Dynamics of epidemiological indicators of thyroid pathology in the population of the Russian Federation: analytical report for the period 2009–2018

BACKGROUND: The level of iodine consumption by the population largery determines the spectrum of thyroid pathology. To date, in the Russian Federation, iodine-deficiency disorders (IDD) occupy a leading position in the structure of all thyroid diseases. Chronic ID leads to adverse health consequences and significant economic costs for their elimination on a national scale. However, the spectrum of thyroid pathology is not limited to the problem of ID, and the study of other thyroid diseases is also of interest.
AIMS: to assess the dynamics of prevalence and incidence of IDD and other thyroid diseases in the entire population of the RF for the period 2009–2018, using official state statistics.
MATERIALS AND METHODS: the main epidemiological indicators (incidence and prevalence) of thyroid diseases in the entire population of the RF were analyzed using official state statistics. The analyzed period is 2009–2018. There was no medical intervention. To assess the dynamics of prevalence and incidence, a linear regression models were constructed, the slope of the trend line was calculated.
RESULTS: the data were analyzed in accordance with the structure of diseases presented in the statistical reporting: goiter, thyroiditis, hypothyroidism, thyrotoxicosis, congenital iodine deficiency syndrome. For the ten-year period 2009–2018 there is a statistically significant increase in the prevalence of various forms of goiter, thyrotoxicosis, congenital iodine deficiency syndrome in the entire population of the Russian Federation. During the observation period, an increase in the incidence of thyrotoxicosis was revealed. With regard to the incidence of congenital iodine deficiency syndrome, only an upward trend was revealed. Despite the fact that during the observation period the number of new cases of various forms of goiter decreased, the prevalence of goiter among the population of the Russian Federation remains high: 1.2% of the population by January 1, 2019. with the growth of autoimmune pathology, improvement of the level of diagnosis, and also, in some cases, with overdiagnosis (for example, when diagnosing autoimmune thyroiditis in individuals with asymptomatic carriage of antithyroid antibodies). The current approaches to iodine prophylaxis are not effective enough.
CONCLUSIONS: the results of the analysis indicate mainly an increase in the high prevalence of thyroid pathology among the population of the RF against the background of regional events. The problem of ID remains unresolved, which dictates the need to introduce universal mandatory salt iodization in the territory of the RF.

1. Hetzel BS. Iodine deficiency disorders (IDD) and their eradication. Lancet. 1983;2(8359):1126-1129. doi: https://doi.org/10.1016/s0140-6736(83)90636-0

2. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286-295. doi: https://doi.org/10.1016/S2213-8587(14)70225-6

3. Rosen SR, Ovadia YS, Anteby EY, et al. Low intake of iodized salt and iodine containing supplements among pregnant women with apparently insufficient iodine status — time to change policy? Isr J Health Policy Res. 2020;9(1):9. doi: https://doi.org/10.1186/s13584-020-00367-4

4. Pearce EN, Andersson M, Zimmermann MB. Global iodine nutrition: Where do we stand in 2013?. Thyroid. 2013;23(5):523-528. doi:10.1089/thy.2013.0128

5. Vučinić M, Kušec V, Dundović S, et al. The effect of 17 years of increased salt iodization on the prevalence and nature of goiter in Croatian schoolchildren. J Pediatr Endocrinol Metab. 2018;31(9):995-1000. doi: https://doi.org/10.1515/jpem-2018-0129

6. Ma ZF, Skeaff SA. Assessment of Population Iodine Status. In Iodine Deficiency Disorders and Their Elimination. Cham, Switzerland: Springer; 2017: 15-28.

7. Sun D, Codling K, Chang S, et al. Eliminating Iodine Deficiency in China: Achievements, Challenges and Global Implications. Nutrients. 2017;9(4):361. doi: https://doi.org/10.3390/nu9040361

8. Melnichenko GA, Troshina EA, Platonova NM, et al. Iodine deficiency thyroid disease in the Russian Federation: the current state of the problem. Аnalytical review of publications and data of official state statistics (Rosstat). Cons Medicum. 2019;21(4):14-20. (In Russ.) doi: https://doi.org/10.26442/20751753.2019.4.190337

9. Platonova NM. Iodine deficiency: current status. Clin Exp Thyroidol. 2015;11(1):12-21. (In Russ.)doi: https://doi.org/10.14341/ket2015112-21

10. Alferova VI, Mustafina SV, Rymar OD, et al. Iodine status of the population in Russia and the world: what do we have for 2019? Clin Exp Thyroidol. 2019;15(2):73-82. (In Russ.. doi: https://doi.org/10.14341/ket10353

11. Laurberg P, Jørgensen T, Perrild H, et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol. 2006;155(2):219-228. doi: https://doi.org/10.1530/eje.1.02210

12. Troshina EA, Platonova NM, Panfilova EA, Panfilov KO. The analytical review of monitoring of the basic epidemiological characteristics of iodine deficiency disorders among the population of the Russian Federation for the period 2009–2015. Problems of Endocrinology. 2018;64(1):21-37. (In Russ.) doi: https://doi.org/10.14341/probl9308

13. National Nutrition Survey (NNS) Aga Khan University. In collaboration UNICEF-Pakistan Medical Research Council (PMRC), Nutrition Wing, Cabinet Division, Ministry of Health, Pakistan; Islamabad, 2001.

14. National Nutrition Survey of Pakistan. PMRC, Nutrition Wing, Cabinet Division, Government of Pakistan; Islamabad, 2011. Р. 33–34.

15. ICCIDD Striking progress against IDD in Pakistan; 50% decrease in iodine deficiency in children over the past decade. IDD News Lett. 2013;2(41):5-20.

16. Vejbjerg P, Knudsen N, Perrild H, et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf ). 2009;71(3):440-445. doi: https://doi.org/10.1111/j.1365-2265.2008.03493.x

17. Laurberg P, Cerqueira C, Ovesen L, et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab. 2010;24(1):13-27. doi: https://doi.org/10.1016/j.beem.2009.08.013

18. Krohn K, Paschke R. Clinical review 133: Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab. 2001;86(7):3336-3345. doi: https://doi.org/10.1210/jcem.86.7.7642

19. Paschke R, Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med. 1997;337(23):1675-1681. doi: https://doi.org/10.1056/NEJM199712043372307

20. Khattak RM, Ittermann T, Nauck M, et al. Monitoring the prevalence of thyroid disorders in the adult population of Northeast Germany. Popul Health Metr. 2016;14:39. doi: https://doi.org/10.1186/s12963-016-0111-3

21. Jayatissa R, Gorstein J, Okosieme OE, et al. Stable Iodine Nutrition During Two Decades of Continuous Universal Salt Iodisation in Sri Lanka. Nutrients. 2020;12(4):1109. doi: https://doi.org/10.3390/nu12041109

22. Rosen SR, Ovadia YS, Anteby EY, et al. Low intake of iodized salt and iodine containing supplements among pregnant women with apparently insufficient iodine status — time to change policy? Isr J Health Policy Res. 2020;9(1):9. doi: https://doi.org/10.1186/s13584-020-00367-4

23. Iodine global network. Annual report. 2019. Available from: https://www.ign.org/cm_data/2019_IGN_Annual_Report_051820.pdf